Trial Profile
Adjunct Dexmedetomidine (Precedex) Therapy Impact on Sedative and Analgesic Requirement.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 11 Oct 2011
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Fentanyl; Propofol
- Indications Pain; Sedation
- Focus Therapeutic Use
- 07 Jul 2011 Planned end date changed from 1 Jul 2009 to 1 Mar 2009 as reported by ClinicalTrials.gov.
- 07 Jul 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 27 Feb 2009 New trial record